SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate received from Link Intime India Pvt. Ltd. (RTA) of the company is enclosed.13-07-2023
13-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of Newspaper Advertisement - Notice for transfer of equity shares and unclaimed dividend to Investor Education and Protection Fund. Account.13-07-2023
Sun Pharma Q1 PAT seen up 8.6% YoY to Rs 2,238.8 cr: Nirmal Bang
Net Sales are expected to increase by 9.5 percent Y-o-Y (up 7.8 percent Q-o-Q) to Rs 11,784.7 crore, according to Nirmal Bang.12-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board Meeting Intimation for Intimation Of Board Meeting
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 ,inter alia, to consider and approve Unaudited Standalone and Consolidated financial results of the company.11-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Company has submitted intimation for Newspaper advertisement - Annual General Meeting to be held through Video Conference/ Other Audio visual means.11-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Record Date For Final Dividend FY2022-23
The Company has fixed Friday, July 28, 2023 as the Record date for the purpose of determining the Members eligible to receive final dividend of Rs.4.00/- per equity share for FY2022-23. The final dividend, if approved at the 31st Annual General Meeting, shall be paid on or before Friday, September 8, 2023.07-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of 31St Annual General Meeting
This is to inform you that the 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3.00 p.m. IST through Video Conferencing/ Other Audio-Visual Means. The Annual Report and the Notice of the AGM for FY2022-23, will be submitted to the stock exchanges and will be sent to the shareholders of the Company in due course.07-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2023 for Aditya Medisales Ltd04-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201503-07-2023
Pick of July 2023: Sun Pharma shares is a hot pick; here's why brokerages recommends to accumulate
Indian markets are expected to be driven by Q1 FY24 earnings and global trends in July. Brokerages recommend accumulating Sun Pharma stock citing positive technical indicators and strong performance in FY23. Sun Pharma's stock has potential upside of 8-12%.02-07-2023